ZyVersa Therapeutics, Inc. (ZVSA)
NasdaqCM - NasdaqCM 延遲價格。貨幣為 USD。
加入追蹤清單
收市：04:00PM EDT
收市後：
| 前收市價 | 6.0000 |
| 開市 | 5.4400 |
| 買盤 | 0.0000 x 0 |
| 賣出價 | 0.0000 x 0 |
| 今日波幅 | 4.4401 - 6.2000 |
| 52 週波幅 | 4.4400 - 220.8500 |
| 成交量 | |
| 平均成交量 | 253,529 |
| 市值 | 37.898M |
| Beta 值 (5 年，每月) | 0.58 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -1,089.7000 |
| 業績公佈日 | 無 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 8.00 |
BenzingaWhy Is Inflammatory Disease-Focused ZyVersa Therapeutics Stock Trading Higher Today?
ZyVersa Therapeutics Inc (NASDAQ:ZVSA) announces the publication of an article in the peer-reviewed journal Acta Neuropathologica Communications, demonstrating that inflammasome activation enhances cancer metastasis to the brain in women with triple-negative breast cancer (TNBC). Up to 40% of women with TNBC experience metastasis to their brain. Published data demonstrate that inflammasome activation increases the proliferation of TNBC cells in the brain, which was prevented by inhibition of NLR
